Memorial Sloan Kettering Commack (All protocol activities)

Commack, New York 11725

4 studies enrolling now · 25 studies all time

What they study most

Adenoid Cystic Carcinoma, Bladder Cancer, Brain Tumor, Breast Conserving Surgery, COVID-19, Cancer, Cancer Pain, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Debulking Surgery for Ovarian Cancer, Endometrial Cancer, Endometrial Cancer Stage I

Studies at this site

• Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease — Recruiting now
• Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery — Recruiting now
• A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer — Recruiting now
• A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change — Recruiting now
• A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers — Running, not enrolling
• Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] — Running, not enrolling
• Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax — Running, not enrolling
• Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors — Running, not enrolling
• The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL) — Running, not enrolling
• A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma — Running, not enrolling
• Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma — Running, not enrolling
• PREPARE: Patient Centered Perioperative Experience — Running, not enrolling
• A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL — Running, not enrolling
• Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma — Completed
• Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma — Running, not enrolling
• A Study of the BREAST-Q REACT Tool for People Having Breast Surgery — Running, not enrolling
• A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer — Running, not enrolling
• Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs — Running, not enrolling
• A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy — Running, not enrolling
• Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer — Completed
• Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT) — Running, not enrolling
• Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers — Running, not enrolling
• A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer — Completed
• A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy — Stopped early